Axial3D

Axial3D

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $4.7M

Overview

Axial3D, founded in 2015 and headquartered in Belfast, is a leader in AI-powered 3D medical imaging for personalized surgery. The company's core technology automates the segmentation of 2D medical scans to create accurate 3D models, streamlining workflows for surgical planning and the development of custom implants and guides. By targeting both MedTech companies and hospitals, Axial3D positions itself at the intersection of digital health and medical devices, enabling a shift from standardized to patient-specific care. Its cloud-based, patented platform is designed for scalability and integration into existing clinical and engineering workflows.

OrthopedicsSurgical Planning

Technology Platform

Patented, AI-driven, cloud-based platform for automated segmentation of DICOM images (CT/MRI) into precise, actionable 3D anatomical models for surgical planning and medical device development.

Funding History

2
Total raised:$4.7M
Series A$3.5M
Seed$1.2M

Opportunities

The global shift towards personalized, value-based healthcare and the rapid growth of the 3D printing and digital surgery markets present a significant expansion opportunity.
Axial3D's dual-sided platform, serving both MedTech companies and hospitals, allows it to capture value across the entire ecosystem of patient-specific care.

Risk Factors

Key risks include slower-than-expected adoption in cost-sensitive hospital systems, intense competition from both large imaging firms and specialized software companies, and the ongoing need to navigate complex regulatory environments as a Software as a Medical Device (SaMD) provider.

Competitive Landscape

Axial3D competes in the medical image segmentation and 3D modeling space against large medical imaging companies (e.g., GE, Siemens), established 3D printing/software specialists (e.g., Materialise, 3D Systems), and a growing number of AI-focused startups. Its differentiation lies in its patented AI, cloud-native scalability, and focused application for scalable patient-specific surgical solutions.